iTeos Therapeutics racks up $125m
Cambridge, Massachusetts-based iTeos Therapeutics, a developer of cancer immunotherapies, has raised $125 million in Series B2 financing.
Cambridge, Massachusetts-based iTeos Therapeutics, a developer of cancer immunotherapies, has raised $125 million in Series B2 financing.
Copyright PEI Media
Not for publication, email or dissemination